| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |